7AY1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Actinium Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.781 EUR Market Closed

Market Cap: €23.3m

	Actinium Pharmaceuticals Inc F:7AY1	US
	La Francaise de l Energie SA PAR:FDE	FR
C	Cleveland-Cliffs Inc XMUN:CVA	US
	La Francaise de l Energie SA OTC:FDENF	FR

Profitability Summary

Actinium Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-40 274%

Negative 3Y Average Operating Margin

-61 149%

Operating Margin is Increasing

-107 369% > -40 274%

Negative Net Margin

-37 652%

Negative 3Y Average Net Margin

-57 117%

Net Margin is Increasing

-102 976% > -37 652%

Negative Free Cash Flow Margin

-27 427%

Negative 3Y Average Free Cash Flow Margin

-48 880%

Free Cash Flow Margin is Increasing

-94 278% > -27 427%

Negative ROE

-167%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2 157%

Declining ROIC

8 338% > 1 029%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.